tirzepatide attenuates mammary tumor progression in diet induced obese mice Is (a glucagon-like peptide-1 (GLP-1) receptor agonist) safe to use patients with breast tumors or a history of breast cancer? The Novel Dual GIP and

GLP1- injections offer cardio protective effects and help reduce the risk of cardiovascular disease (CVD) in adults with type 2 diabetes (T2DM) or high atherosclerotic cardiovascular disease (ASCVD) risk

97112 Neuromuscular Re-education: For balance and coordination deficits

Provide the correct IUPAC name for Sn(NO2)4 Provide the correct IUPAC name for Se2l8

The stress response to surgery typically raises blood glucose levels, making perioperative diabetes management a careful balance

The development of GLP-1 receptor agonists for type 2 diabetes was contextualised within the broader research landscape, including orally bioavailable agonists, allosteric modulators, and unimolecular multi-agonists all of which use the native GLP-1 receptor as their primary target

MiR-200b in Heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3